SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 76 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,018,472 | -35.1% | 2,121,289 | +15.0% | 0.00% | – |
| Q2 2023 | $12,362,786 | +11.9% | 1,845,192 | +8.7% | 0.00% | – |
| Q1 2023 | $11,051,617 | -23.2% | 1,697,637 | +0.6% | 0.00% | – |
| Q4 2022 | $14,397,957 | +150.8% | 1,687,920 | +55.3% | 0.00% | – |
| Q3 2022 | $5,740,000 | +28.1% | 1,087,171 | +2.9% | 0.00% | – |
| Q2 2022 | $4,480,000 | +55.0% | 1,056,664 | +28.3% | 0.00% | – |
| Q1 2022 | $2,890,000 | -66.9% | 823,296 | -37.2% | 0.00% | – |
| Q4 2021 | $8,735,000 | -47.6% | 1,311,666 | -21.4% | 0.00% | – |
| Q3 2021 | $16,657,000 | -45.8% | 1,669,094 | +67.7% | 0.00% | -100.0% |
| Q2 2021 | $30,752,000 | -35.1% | 995,550 | -8.3% | 0.00% | 0.0% |
| Q1 2021 | $47,361,000 | +1944.9% | 1,085,492 | +2071.0% | 0.00% | – |
| Q4 2020 | $2,316,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 1,910,029 | $10,085,000 | 3.26% |
| K2 PRINCIPAL FUND, L.P. | 3,247,533 | $16,890,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 1,045,234 | $5,519,000 | 1.09% |
| Orbimed Advisors | 8,740,887 | $46,152,000 | 0.86% |
| Rubric Capital Management LP | 2,695,170 | $14,230,000 | 0.72% |
| Prosight Management, LP | 196,257 | $1,036,000 | 0.56% |
| Nantahala Capital Management | 1,249,863 | $6,599,000 | 0.43% |
| Oasis Management Co Ltd. | 317,662 | $1,677,000 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 409,463 | $2,162,000 | 0.26% |
| APOGEM CAPITAL LLC | 13,793 | $73,000 | 0.07% |